| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 12.513 | 26.810 | 25.499 | 28.639 | 37.577 |
| Total Income - EUR | - | - | - | - | - | 12.513 | 26.910 | 25.499 | 28.639 | 37.610 |
| Total Expenses - EUR | - | - | - | - | - | 1.927 | 2.677 | 2.401 | 9.657 | 24.839 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 10.587 | 24.232 | 23.098 | 18.981 | 12.771 |
| Net Profit/Loss - EUR | - | - | - | - | - | 10.226 | 23.522 | 22.428 | 15.701 | 10.453 |
| Employees | - | - | - | - | - | 0 | 0 | 0 | 0 | 1 |
Check the financial reports for the company - Necuderm S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | 10.600 | 28.459 | 22.678 | 18.506 | 12.588 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 269 | 154 | 13.645 | 16.481 | 1.239 |
| Cash | - | - | - | - | - | 10.331 | 28.305 | 9.033 | 2.025 | 11.349 |
| Shareholders Funds | - | - | - | - | - | 10.267 | 27.699 | 22.477 | 15.750 | 10.502 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 333 | 760 | 201 | 2.756 | 2.197 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Necuderm S.r.l.